Phase Genomics Announces 6 New Asia Pacific Distribution Partnerships
New cutting-edge tools and services to fuel genomic discovery in humans, plants, animals and microbiome research now available in South Korea, Japan, China, Singapore, Malaysia, Indonesia, New Zealand and Australia
Seattle, Oct. 21, 2018 (GLOBE NEWSWIRE) — Phase Genomics, the leader in Hi-C proximity-ligation based genomic solutions, announced today agreements with six life science technology distributors serving much of Asia Pacific. Phase Genomics sells Hi-C kits paired with proprietary analysis software that allows researchers studying humans, plants, animals, and microbes a time-saving and inexpensive genomic discovery platform. The Hi-C kit, contrary to traditional methods, provides an easy-to-use protocol that lets scientists generate a sequencer-ready Hi-C library from almost any sample in as little as eight hours.
Dr. Ivan Liachko, CEO and Co-founder of Phase Genomics commented, “With our new partnerships, Phase Genomics is proud to expand our reach and provide more scientists and researchers throughout Asia, Australia, and New Zealand with the tools, services, and analyses needed to produce the world’s best genome and metagenome assemblies. The results generated with our technology offer researchers a new dimension of genomic information, produce novel discoveries, and save scientists both time and money.”
Phase Genomics applies Hi-C and other proprietary proximity-ligation methods to enable chromosome-scale genome assembly, metagenome deconvolution, as well as analysis of structural genomic variation and genome architecture. The United States based company offers a comprehensive portfolio of laboratory and computational services and products, which are now available through the new Asia Pacific partnerships. Products include ProxiMeta™ Hi-C metagenome assembly kits and Proximo™ Hi-C genome assembly kits as well as industry-leading analysis services.
The non-exclusive distribution partnerships include:
- Filgen Biosciences & Nanosciences (Japan)
- Genetimes Technology (China)
- Genosys Inc. (China)
- Integrated Sciences (Australia and New Zealand)
- Phyzen (South Korea)
- Sciencewerke (Singapore, Malaysia, Indonesia)
Phase Genomics’ technology powers scientists to advance research with breakthrough discoveries in human disease, agricultural breeding and sustainability, animal health, reference genomes, and the environment.
ABOUT PHASE GENOMICS – Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples as well as industry-leading genome and metagenome assembly and analysis software.
Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.
Eric Schudiske s2s Public Relations 12063103597 firstname.lastname@example.org